⚡ This is your brand? Claim your page FREE and bring it to life on AI search.

AI Visibility Scorecard

ZEPZELCA® (lurbinectedin) for small cell lung cancer (SCLC)

ZEPZELCA® (lurbinectedin) for small cell lung cancer (SCLC)

Unclaimed

zepzelca.com · Healthcare

Somewhat visible. AI bots can read ZEPZELCA® (lurbinectedin) for small cell lung cancer (SCLC), but it is missing the structured signals that push citation rate above competitors.

AI engines read this profile 2 times

Claude · Apple Intelligence

#57,876 of 835,278 in Healthcare for AI visibility

6

/10

AEO Score

Share

About ZEPZELCA® (lurbinectedin) for small cell lung cancer (SCLC)

from our crawl and measurement

ZEPZELCA® (lurbinectedin) for small cell lung cancer (SCLC) is a business whose own site puts it this way: "ZEPZELCA® (lurbinectedin) is used to treat adults with small cell lung cancer (SCLC)." To AI engines like ChatGPT and Perplexity it is partially visible, scoring 6.0 out of 10, readable in places and missing in others.

Our crawl found a sitemap and a readable heading structure. It is missing structured data describing the business and an llms.txt file.

AI crawlers have visited once in our tracking, including ClaudeBot (Anthropic).

Industry · Healthcare
Last scored · Aug 8, 2026

The 6 signals AI reads

Higher is better · 0-10

Structured Data

2

Organization / LocalBusiness JSON-LD that AI can read.

Content Structure

10

Clear headings and answer-style content.

Entity Clarity

6

How clearly your brand identity reads to AI.

E-E-A-T Signals

Experience, Expertise, Authority, Trust

2

Experience, Expertise, Authority, Trust markers.

Technical AEO

7

robots.txt, llms.txt, and AI-bot crawl access.

AI Discoverability

7

Sitemaps and entity links AI can follow.

Off-page authority

How the web signals your brand to AI

Backlinks

9

Inbound links from other sites.

Domain Authority

3

Established authority for your domain.

Reference Presence

0

Not in AI knowledge graphs yet.

News & Press

0

No press coverage found yet.

Community

0

No community discussion yet.

Social Mentions

0

No social discussion found yet.

What this score means

Your AEO score measures whether AI search engines - ChatGPT, Claude, Perplexity, Gemini - can actually read your site and cite it in answers. Roughly two-thirds of sites are invisible to them. At 6/10, ZEPZELCA® (lurbinectedin) for small cell lung cancer (SCLC) has a working base to build on - fixable, and the signals above are where to start.

Is this your brand?

The exact fixes for ZEPZELCA® (lurbinectedin) for small cell lung cancer (SCLC)

Which AI engines already crawl you

Weekly ChatGPT & Claude citation tracking

Already have an account? Sign in

Picked for ZEPZELCA® (lurbinectedin) for small cell lung cancer (SCLC): How-To

How to Get Your Brand Cited by ChatGPT, Gemini, and Claude: The Complete AEO Guide

The search landscape has fundamentally shifted. While Google still dominates, millions of users now ask questions to ChatGPT, Gemini, and Claude instead of typing into a search bar.

Continue reading in your free Engagemii portal

Free signup unlocks the full article plus your personalized AEO fix list for ZEPZELCA® (lurbinectedin) for small cell lung cancer (SCLC).

Source & Attribution

Scored by Engagemii on August 8, 2026. Methodology: engagemii.com/aeo/methodology

Source URL: https://engagemii.com/aeo/brands/zepzelca

Cite this score: Engagemii (2026). "AEO Score for ZEPZELCA® (lurbinectedin) for small cell lung cancer (SCLC)." Retrieved from https://engagemii.com/aeo/brands/zepzelca

Licensed under CC BY 4.0. You may reuse this data with attribution: a visible link to engagemii.com.

Powered by Engagemii - The Answer Engine Optimization (AEO) Platform